发明名称 |
Modulation of monocytes, or precursors thereof, differentiation |
摘要 |
The invention is generally directed to promoting dendritic cells (DCs), and optionally M1-type (macrophage M1 polarization), immune response by administering a compound that modulates macrophage polarization. The invention is directed to the use of an antibody able to bind to CSF-1R for modulating macrophage polarization. The invention is also directed to methods for evaluating the dose efficacy of an antibody able to bind to CSF-1R in a patient by assessing the in vivo or in vitro polarization of macrophages. The invention is further directed to post-treatment companion test and assays to assess the effect of an antibody able to bind to CSF-1R on a subject being treated. |
申请公布号 |
AU2013343556(A1) |
申请公布日期 |
2015.04.30 |
申请号 |
AU20130343556 |
申请日期 |
2013.11.08 |
申请人 |
TRANSGENE SA |
发明人 |
HAEGEL, HELENE;HALLET, REMY |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|